Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

29.20 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 74,143
Open 29.20
Bid (Size) 29.22 (3)
Ask (Size) 29.23 (1)
Prev. Close 29.20
Today's Range 29.20 - 29.20
52wk Range 25.20 - 33.92
Shares Outstanding 5,606,688,356
Dividend Yield 5.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer sees stock gains following a $1 billion investment by Starboard Value and a favorable UK court ruling invalidating two GSK RSV vaccine patents. Pfizer and GSK continue their legal battles as... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
-1.78%
-1.78%
1 Month
-0.71%
-0.71%
3 Month
+4.55%
+4.55%
6 Month
+9.86%
+9.86%
1 Year
-12.05%
-12.05%

More News

Read More
Starboard Value Reportedly Acquires $1B Stake In Pfizer As Stock Lags S&P 500 By 46%
Via Talk Markets
Topics Stocks
Exposures US Equities
Pfizer Stock Is Moving Higher Monday: What's Driving The Action?
Via Benzinga
Why Pfizer Stock Popped on Monday
Via The Motley Fool
Behind the Scenes of Pfizer's Latest Options Trends
Via Benzinga
Key Takeaways From Pfizer Analyst Ratings
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
Via Investor's Business Daily
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Via Benzinga
Exposures COVID-19
Wall Street Set To Start New Week Sharply Lower As Traders Brace For Key Economic Data And Fed Minutes: Why Strategist Sees Market Consolidating In Near Term
Via Benzinga
Topics Economy
Exposures Interest Rates
Amid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report
Via Benzinga
Exposures COVID-19
3 High-Yield Dividend Stocks That Are Screaming Buys Right Now
Via The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
Via The Motley Fool
Want Over $5,000 in Annual Dividends? Invest $23,000 in Each of These 3 Stocks
Via The Motley Fool
Election Outcome Presents Opportunity For Investors
Via Talk Markets
Topics Government
Exposures Political
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Via Investor's Business Daily
3 Top Stocks That Could Still Rocket Higher in 2024
Via The Motley Fool
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Via Benzinga
3 Stocks Set to Benefit from Cooling Inflation Trends
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Is Pfizer a Buy Right Now or a Value Trap?
Via The Motley Fool
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Via Benzinga
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
Via The Motley Fool
Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?
Via The Motley Fool
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Via Benzinga
Topics Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.